Biotransformation of Betulonic Acid by the Fungus <i>Rhizopus arrhizus</i> CGMCC 3.868 and Antineuroinflammatory Activity of the Biotransformation Products
Kainan Song, Youjia Lu, Chengjiao Chu, Yanni Wu, Huilian Huang, Bo‐Yi Fan, Guangtong Chen
Abstract
Biotransformation of betulonic acid (1) by Rhizopus arrhizus CGMCC 3.868 resulted in the production of 16 new (3, 5, 6, and 9–21) and five known compounds. Structures of the new compounds were established by analysis of spectroscopic data. Hydroxylation, acetylation, oxygenation, glycosylation, and addition reactions involved the C-20–C-29 double bond. Antineuroinflammatory activities of the obtained compounds in NO production were tested in lipopolysaccharides-induced BV-2 cells. Compared with the substrate betulonic acid, biotransformation products 3, 8, 9, 14, and 21 exhibited an improved inhibitory effect, with IC50 values of 10.26, 11.09, 5.38, 1.55, and 4.69 μM, lower than that of the positive control, NG-monomethyl-l-arginine.